Published in Calcif Tissue Int on December 04, 2007
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
Genetics of osteoporosis: accelerating pace in gene identification and validation. Hum Genet (2009) 1.14
Molecular genetic studies of gene identification for osteoporosis: the 2009 update. Endocr Rev (2010) 1.00
Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis. BMC Med Genet (2008) 0.96
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women. BMC Musculoskelet Disord (2014) 0.79
A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene and bone mineral density in Japanese male workers. Environ Health Prev Med (2010) 0.78
Genetic analysis of the relationship between bone mineral density and low-density lipoprotein receptor-related protein 5 gene polymorphisms. PLoS One (2013) 0.78
Genetic influence of candidate osteoporosis genes in saudi arabian population: a pilot study. J Osteoporos (2012) 0.78
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med (2002) 11.28
GOLD--graphical overview of linkage disequilibrium. Bioinformatics (2000) 9.43
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet (2001) 6.56
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol (2002) 6.20
Genetics and biology of vitamin D receptor polymorphisms. Gene (2004) 4.60
High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res (2003) 3.48
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet (2003) 2.86
Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol (2004) 2.59
Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem (1989) 2.37
Genetic factors in determining bone mass. J Clin Invest (1973) 2.35
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet (2004) 1.97
Heritable and life-style determinants of bone mineral density. J Bone Miner Res (1993) 1.78
Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques (2001) 1.62
Bone biomechanical properties in LRP5 mutant mice. Bone (2004) 1.47
LRP5, low-density-lipoprotein-receptor-related protein 5, is a determinant for bone mineral density. J Hum Genet (2004) 1.47
Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J Clin Endocrinol Metab (2000) 1.43
Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum Mol Genet (2005) 1.42
Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J Bone Miner Res (2005) 1.37
A whole-genome linkage scan suggests several genomic regions potentially containing quantitative trait Loci for osteoporosis. J Clin Endocrinol Metab (2002) 1.33
Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res (2004) 1.26
Sex-specific and non-sex-specific quantitative trait loci contribute to normal variation in bone mineral density in men. J Clin Endocrinol Metab (2005) 1.23
Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res (2000) 1.19
Bone density determinants in elderly women: a twin study. J Bone Miner Res (1995) 1.18
Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13. J Bone Miner Res (1998) 1.18
Influence of LRP5 polymorphisms on normal variation in BMD. J Bone Miner Res (2004) 1.14
LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone (2005) 1.11
Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul (1995) 1.08
Determinants of bone mass in 10- to 26-year-old females: a twin study. J Bone Miner Res (1995) 1.05
Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas (2005) 1.03
Association between bone mineral density and LDL receptor-related protein 5 gene polymorphisms in young Korean men. J Korean Med Sci (2004) 0.95
LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone (2005) 0.94
Gender differences in the genetic factors responsible for variation in bone density and ultrasound. J Bone Miner Res (2002) 0.93
MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study. Bone (2005) 0.90
Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study. Int J Obes (Lond) (2006) 0.88
Association of polymorphisms of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics (2001) 0.82
Genetic determinants of bone mass. Horm Res (1999) 0.82
Genetics of osteoporosis. Curr Rheumatol Rep (2005) 0.81
Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int (1999) 0.81
The roles of adulthood behavioural factors and familial influences in bone density among men. Ann Med (2002) 0.77
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30
Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study. Osteoporos Int (2012) 3.13
Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg (1997) 3.10
Is the use of dummy or carry-cot of importance for sudden infant death? Eur J Pediatr (1997) 3.06
Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab (2001) 2.98
Germline mosaicism and Duchenne muscular dystrophy mutations. Nature (1987) 2.56
The epidemic of type 2 diabetes is a statistical artefact. Diabetologia (2005) 2.41
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Cerebral astrocyte response to micromachined silicon implants. Exp Neurol (1999) 2.37
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nat Genet (1992) 2.18
Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age. BMJ (1993) 2.16
A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res (2000) 2.16
Parity and tanned white skin as novel predictors of vitamin D status in early pregnancy: a population-based cohort study. Clin Endocrinol (Oxf) (2013) 2.16
Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet (2001) 2.15
PBS/RPBS cost implications of trends and guideline recommendations in the pharmacological management of hypertension in Australia, 1994-1998. Med J Aust (2001) 2.15
Are H2 receptor antagonists safe over the counter drugs? BMJ (1994) 2.07
Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest (1980) 2.04
Heart failure in patients treated with bisphosphonates. J Intern Med (2013) 2.00
Statins and risk of polyneuropathy: a case-control study. Neurology (2002) 1.97
The Danish 1905 cohort: a genetic-epidemiological nationwide survey. J Aging Health (2001) 1.97
Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science (1990) 1.92
SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed (1997) 1.88
Lifetime risk and projected population prevalence of diabetes. Diabetologia (2008) 1.73
Van der Waals interactions between cell surfaces. J Membr Biol (1977) 1.71
EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet (1999) 1.70
Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet (2005) 1.69
Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature (1987) 1.68
Microanalysis and characterization of acidic glycosaminoglycans in human tissues. Anal Biochem (1970) 1.66
Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy. Br J Psychiatry (2001) 1.66
A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int (2005) 1.65
Mutagenic action of isocyanates used in the production of polyurethanes. Scand J Work Environ Health (1980) 1.64
Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease. Nat Genet (2000) 1.63
Depressed lymphocyte response to P.H.A. in women taking oral contraceptives. Lancet (1972) 1.60
Positional cloning of a gene involved in hereditary multiple exostoses. Hum Mol Genet (1996) 1.58
Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet (1992) 1.57
The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review. Pharmacoepidemiol Drug Saf (2013) 1.53
Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy. Br J Clin Pharmacol (2000) 1.49
The activity of satellite cells and myonuclei following 8 weeks of strength training in young men with suppressed testosterone levels. Acta Physiol (Oxf) (2014) 1.43
Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest (1978) 1.42
Communication abilities in hemiplegia: effect of speech therapy. Arch Phys Med Rehabil (1973) 1.42
Localization of the gene for hyperostosis cranialis interna to chromosome 8p21 with analysis of three candidate genes. Calcif Tissue Int (2013) 1.41
Should smoking be an indication for lipid-lowering therapy? Med J Aust (1999) 1.40
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses. Am J Hum Genet (1998) 1.39
Usefulness of magnetic resonance-derived quantitative measurements of cerebral blood flow and volume in prediction of infarct growth in hyperacute stroke. Stroke (2001) 1.39
No long-term excess mortality after measles infection: a community study from Senegal. Am J Epidemiol (1996) 1.39
Acute hepatitis and roxithromycin. Lancet (1993) 1.39
[Exposure to blood and risk of infection among health personnel]. Ugeskr Laeger (1993) 1.39
The human extracellular matrix gene 1 (ECM1): genomic structure, cDNA cloning, expression pattern, and chromosomal localization. Genomics (1997) 1.38
Medical teaching in sioux lookout: primary health care in a cross-cultural setting. Can Fam Physician (1989) 1.38
Prolactin, TSH, LH and FSH responses to a combined LHRH-TRH test at different stages of the menstrual cycle. Clin Endocrinol (Oxf) (1974) 1.37
Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes. Hum Mutat (2000) 1.36
Disulfiram therapy--adverse drug reactions and interactions. Acta Psychiatr Scand Suppl (1992) 1.36
The mental health of women 6 months after they give birth to an unwanted baby: a longitudinal study. Soc Sci Med (1991) 1.33
Contacts to the health care system prior to suicide: a comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners and practising specialists and drug prescriptions. Acta Psychiatr Scand (2000) 1.32
Antidepressant medications and osteoporosis. Bone (2012) 1.28
Strength and anthropometric measures in identical and fraternal twins: no evidence of masculinization of females with male co-twins. Epidemiology (2000) 1.28
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26
Hereditary multiple exostoses: from genetics to clinical syndrome and complications. Eur J Radiol (2001) 1.26
The effect of obesity prevention interventions according to socioeconomic position: a systematic review. Obes Rev (2014) 1.26
Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr (1997) 1.25
Drug-induced thrombocytopenia: clinical data on 309 cases and the effect of corticosteroid therapy. Eur J Clin Pharmacol (1997) 1.24
Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21. Am J Hum Genet (1999) 1.23
Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostosis, and mental retardation, caused by deletions in the short arm of chromosome 11. Am J Hum Genet (1996) 1.23
Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data. Br J Clin Pharmacol (1997) 1.22
X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood (2000) 1.21
Identification of mutations in the MSX2 homeobox gene in families affected with foramina parietalia permagna. Hum Mol Genet (2000) 1.20
Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am J Hum Genet (1998) 1.20
Impact of family type and family quality on child behavior problems: a longitudinal study. J Am Acad Child Adolesc Psychiatry (1997) 1.19
Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J Neurol Neurosurg Psychiatry (2006) 1.18
Fast FLAIR sequence for detecting major vascular abnormalities during the hyperacute phase of stroke: a comparison with MR angiography. Neuroradiology (1999) 1.17
Sclerosing bone dysplasias: genetic and radioclinical features. Eur Radiol (2000) 1.17
Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur J Hum Genet (1998) 1.17
Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15. Hum Mol Genet (1995) 1.17
Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab (2009) 1.17
Camurati-Engelmann disease. Review of radioclinical features. Acta Radiol (2003) 1.16
Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun (2006) 1.15
Identification of chromosome 21 DNA polymorphisms for genetic studies in Alzheimer's disease and Down syndrome. Hum Genet (1991) 1.14
Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35. Am J Hum Genet (2001) 1.14
Exercise-induced changes in local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab (1996) 1.14
Increasing body weight and risk of limitations in activities of daily living: a systematic review and meta-analysis. Obes Rev (2011) 1.13
Sclerostin in mineralized matrices and van Buchem disease. J Dent Res (2009) 1.11
Physical mapping of chromosome 21 DNA markers in Alzheimer's disease region using somatic cell hybrids. Somat Cell Mol Genet (1990) 1.10
Double blind randomised controlled trial of effect of metoprolol on myocardial ischaemia during endoscopic cholangiopancreatography. BMJ (1996) 1.09
Changes in the epidemiological pattern of sudden infant death syndrome in southeast Norway, 1984-1998: implications for future prevention and research. Arch Dis Child (2001) 1.09
Influence of lactation on oral glucose tolerance in the puerperium. Acta Endocrinol (Copenh) (1981) 1.09
Phytoene desaturase is localized exclusively in the chloroplast and up-regulated at the mRNA level during accumulation of secondary carotenoids in Haematococcus pluvialis (Volvocales, chlorophyceae). Plant Physiol (2000) 1.09